Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Acute Leukemias

Risk score model for fatal intracranial hemorrhage in acute leukemia

Abstract

To build a risk score (RS) model of fatal intracranial hemorrhage (FICH) in patients with acute leukemia, we retrospectively assessed risk factors in 792 patients newly diagnosed with acute leukemia, 41 of whom had analyzable FICH. We found that female gender (relative risk (RR)=5.234, P<0.001), acute promyelocytic leukemia (RR=4.057, P=0.003), leukocytosis (RR=3.301, P=0.004), thrombocytopenia (RR=3.283, P=0.005) and prolonged prothrombin time (RR=3.291, P=0.016) were significantly associated with occurrence of FICH in multivariate analysis. To calculate RS for FICH, one point was assigned for each risk factor, making the RS between 0 and 5. The RS model segregated patients into three prognostic groups: a low-risk group (LRG) for RS of 0 or 1; an intermediate-risk group (IRG) for RS of 2 or 3; and a high-risk group (HRG) for RS of 4 or 5. Expectation of FICH was well correlated with risk groups (all P-values <0.001). Overall survival was significantly shorter in the HRG compared with the LRG. The RS model we constructed to predict the occurrence of FICH will be verified through prospective studies.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Ribeiro RC, Pui CH . The clinical and biological correlates of coagulopathy in children with acute leukemia. J Clin Oncol 1986; 4: 1212–1218.

    Article  CAS  PubMed  Google Scholar 

  2. Chang HY, Rodriguez V, Narboni G, Bodey GP, Luna MA, Freireich EJ . Causes of death in adults with acute leukemia. Medicine (Baltimore) 1976; 55: 259–268.

    Article  CAS  Google Scholar 

  3. Dutcher JP, Schiffer CA, Wiernik PH . Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival. J Clin Oncol 1987; 5: 1364–1372.

    Article  CAS  PubMed  Google Scholar 

  4. Visani G, Gugliotta L, Tosi P, Catani L, Vianelli N, Martinelli G et al. All-trans retinoic acid significantly reduces the incidence of early hemorrhagic death during induction therapy of acute promyelocytic leukemia. Eur J Haematol 2000; 64: 139–144.

    Article  CAS  PubMed  Google Scholar 

  5. Frankel SR, Eardley A, Heller G, Berman E, Miller Jr WH, Dmitrovsky E et al. All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study. Ann Intern Med 1994; 120: 278–286.

    Article  CAS  PubMed  Google Scholar 

  6. Kanamaru A, Takemoto Y, Tanimoto M, Murakami H, Asou N, Kobayashi T et al. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group. Blood 1995; 85: 1202–1206.

    CAS  PubMed  Google Scholar 

  7. Estey E, Thall PF, Pierce S, Kantarjian H, Keating M . Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine. J Clin Oncol 1997; 15: 483–490.

    Article  CAS  PubMed  Google Scholar 

  8. Pochedly C . Neurologic manifestations in acute leukemia. I. Symptoms due to increased cerebrospinal fluid pressure and hemorrhage. NY State J Med 1975; 75: 575–580.

    CAS  Google Scholar 

  9. Creutzig U, Ritter J, Budde M, Sutor A, Schellong G . Early deaths due to hemorrhage and leukostasis in childhood acute myelogenous leukemia. Associations with hyperleukocytosis and acute monocytic leukemia. Cancer 1987; 60: 3071–3079.

    Article  CAS  PubMed  Google Scholar 

  10. Di Bona E, Avvisati G, Castaman G, Luce Vegna M, De Sanctis V, Rodeghiero F et al. Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia. Br J Haematol 2000; 108: 689–695.

    Article  CAS  PubMed  Google Scholar 

  11. Higuchi T, Shimizu T, Mori H, Niikura H, Omine M . Coagulation patterns of disseminated intravascular coagulation in acute promyelocytic leukemia. Hematol Oncol 1997; 15: 209–217.

    Article  CAS  PubMed  Google Scholar 

  12. Kim H, Lee JH, Choi SJ, Kim WK, Lee JS, Lee KH . Analysis of fatal intracranial hemorrhage in 792 acute leukemia patients. Haematologica 2004; 89: 622–624.

    PubMed  Google Scholar 

  13. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposals for the classification of the acute leukaemias. French–American–British (FAB) co-operative group. Br J Haematol 1976; 33: 451–458.

    Article  CAS  PubMed  Google Scholar 

  14. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849.

    Article  CAS  PubMed  Google Scholar 

  15. Avvisati G, ten Cate JW, Buller HR, Mandelli F . Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia. Lancet 1989; 2: 122–124.

    Article  CAS  PubMed  Google Scholar 

  16. Groch SN, Sayre GP, Heck FJ . Cerebral hemorrhage in leukemia. Arch Neurol 1960; 2: 439–451.

    Article  CAS  PubMed  Google Scholar 

  17. McCormick WF, Rosenfield DB . Massive brain hemorrhage: a review of 144 cases and an examination of their causes. Stroke 1973; 4: 946–954.

    Article  CAS  PubMed  Google Scholar 

  18. Parma M, Casaroli I, Pogliani EM . Occurrence of cerebellar thrombohemorrhage during all-trans retinoic acid (ATRA) therapy in a case of acute promyelocytic leukemia. Haematologica 1996; 81: 379–380.

    CAS  PubMed  Google Scholar 

  19. Chen CY, Zimmerman RA, Faro S, Bilaniuk LT, Chou TY, Molloy PT . Childhood leukemia: central nervous system abnormalities during and after treatment. Am J Neuroradiol 1996; 17: 295–310.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Chung CY, Hsu NC, Horng HC, Chang CS . Successful treatment for multiple cerebral hemorrhage in a newly diagnosed patient with acute promyelocytic leukemia. Leukemia Lymphoma 2003; 44: 1059–1061.

    Article  CAS  PubMed  Google Scholar 

  21. Priest JR, Ramsay NK, Latchaw RE, Lockman LA, Hasegawa DK, Coates TD et al. Thrombotic and hemorrhagic strokes complicating early therapy for childhood acute lymphoblastic leukemia. Cancer 1980; 46: 1548–1554.

    Article  CAS  PubMed  Google Scholar 

  22. Hara T, Kishikawa T, Miyazaki S, Ishii E, Goya N . Central nervous system complications in childhood leukemia. Correlation between clinical and computed tomographic findings. Am J Pediatr Hematol Oncol 1984; 6: 129–136.

    Article  CAS  PubMed  Google Scholar 

  23. Feldman EJ, Arlin ZA, Ahmed T, Mittelman A, Ascensao JL, Puccio CA et al. Acute promyelocytic leukemia: a 5-year experience with new antileukemic agents and a new approach to preventing fatal hemorrhage. Acta Haematol 1989; 82: 117–121.

    Article  CAS  PubMed  Google Scholar 

  24. Arlin ZA, Feldman EJ . Treatment of DIC associated with APL. Blood 1990; 76: 2418.

    CAS  PubMed  Google Scholar 

  25. Sarris A, Cortes J, Kantarjian H, Pierce S, Smith T, Keating M et al. Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dl. Leukemia Lymphoma 1996; 21: 85–92.

    Article  CAS  PubMed  Google Scholar 

  26. Hongo T, Okada S, Ohzeki T, Ohta H, Nishimura S, Hamamoto K et al. Low plasma levels of hemostatic proteins during the induction phase in children with acute lymphoblastic leukemia: a retrospective study by the JACLS. Japan Association of Childhood Leukemia Study. Pediatr Int 2002; 44: 293–299.

    Article  CAS  PubMed  Google Scholar 

  27. Tornebohm E, Blomback M, Lockner D, Egberg N, Paul C . Bleeding complications and coagulopathy in acute leukaemia. Leukemia Res 1992; 16: 1041–1048.

    Article  CAS  Google Scholar 

  28. Sarris AH, Kempin S, Berman E, Michaeli J, Little C, Andreeff M et al. High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia. Blood 1992; 79: 1305–1310.

    CAS  PubMed  Google Scholar 

  29. Wilde JT, Davies JM . Haemostatic problems in acute leukaemia. Blood Rev 1990; 4: 245–251.

    Article  CAS  PubMed  Google Scholar 

  30. Ventura GJ, Hester JP, Dixon DO, Khorana S, Keating MJ . Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia. Hematol Pathol 1989; 3: 23–28.

    CAS  PubMed  Google Scholar 

  31. Park BH, Lavi E, Blank KJ, Gaulton GN . Intracerebral hemorrhages and syncytium formation induced by endothelial cell infection with a murine leukemia virus. J Virol 1993; 67: 6015–6024.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Humphries JE, Hess CE, Stewart FM . Acute promyelocytic leukemia: impact of hemorrhagic complications on response to induction chemotherapy and survival. South Med J 1990; 83: 1157–1161.

    Article  CAS  PubMed  Google Scholar 

  33. Jerde O . Bleeding problems in leukemia. Minn Med 1966; 49: 1457–1461.

    CAS  PubMed  Google Scholar 

  34. Gmur J, Burger J, Schanz U, Fehr J, Schaffner A . Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet 1991; 338: 1223–1226.

    Article  CAS  PubMed  Google Scholar 

  35. Rebulla P, Finazzi G, Marangoni F, Avvisati G, Gugliotta L, Tognoni G et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N Engl J Med 1997; 337: 1870–1875.

    Article  CAS  PubMed  Google Scholar 

  36. Vahdat L, Maslak P, Miller Jr WH, Eardley A, Heller G, Scheinberg DA et al. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood 1994; 84: 3843–3849.

    CAS  PubMed  Google Scholar 

  37. Bunin NJ, Pui CH . Differing complications of hyperleukocytosis in children with acute lymphoblastic or acute nonlymphoblastic leukemia. J Clin Oncol 1985; 3: 1590–1595.

    Article  CAS  PubMed  Google Scholar 

  38. Rodeghiero F, Avvisati G, Castaman G, Barbui T, Mandelli F . Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients. Blood 1990; 75: 2112–2117.

    CAS  PubMed  Google Scholar 

  39. Kawakami Y, Ueki K, Chikama M, Shimamura Y, Naito T . Intracranial hemorrhage associated with nontraumatic disseminated intravascular coagulation--report of four cases. Neurol Med Chir (Tokyo) 1990; 30: 610–617.

    Article  CAS  Google Scholar 

  40. Goldberg MA, Ginsburg D, Mayer RJ, Stone RM, Maguire M, Rosenthal DS et al. Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia? Blood 1987; 69: 187–191.

    CAS  PubMed  Google Scholar 

  41. Kantarjian HM, Keating MJ, Walters RS, Estey EH, McCredie KB, Smith TL et al. Acute promyelocytic leukemia. M.D. Anderson Hospital experience. Am J Med 1986; 80: 789–797.

    Article  CAS  PubMed  Google Scholar 

  42. Cordonnier C, Vernant JP, Brun B, Heilmann MG, Kuentz M, Bierling P et al. Acute promyelocytic leukemia in 57 previously untreated patients. Cancer 1985; 55: 18–25.

    Article  CAS  PubMed  Google Scholar 

  43. Groopman J, Ellman L . Acute promyelocytic leukemia. Am J Hematol 1979; 7: 395–408.

    Article  CAS  PubMed  Google Scholar 

  44. Nilsson OG, Lindgren A, Brandt L, Saveland H . Prediction of death in patients with primary intracerebral hemorrhage: a prospective study of a defined population. J Neurosurg 2002; 97: 531–536.

    Article  PubMed  Google Scholar 

  45. Farley TM, Meirik O, Collins J . Cardiovascular disease and combined oral contraceptives: reviewing the evidence and balancing the risks. Hum Reprod Update 1999; 5: 721–735.

    Article  CAS  PubMed  Google Scholar 

  46. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case–control study. Lancet 1996; 348: 505–510.

  47. Ayala C, Croft JB, Greenlund KJ, Keenan NL, Donehoo RS, Malarcher AM et al. Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995–1998. Stroke 2002; 33: 1197–1201.

    Article  PubMed  Google Scholar 

  48. Nilsson OG, Lindgren A, Stahl N, Brandt L, Saveland H . Incidence of intracerebral and subarachnoid haemorrhage in southern Sweden. J Neurol Neurosurg Psychiatry 2000; 69: 601–607.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K-H Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, H., Lee, JH., Choi, SJ. et al. Risk score model for fatal intracranial hemorrhage in acute leukemia. Leukemia 20, 770–776 (2006). https://doi.org/10.1038/sj.leu.2404148

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404148

Keywords

This article is cited by

Search

Quick links